HARNESSING CD38: THE FUTURE OF MULTIPLE MYELOMA THERAPY

Harnessing CD38: The Future of Multiple Myeloma Therapy

Harnessing CD38: The Future of Multiple Myeloma Therapy CD38-Directed Therapies: Transforming the Multiple Myeloma Treatment Landscape Multiple Myeloma, a type of blood cancer originating in plasma cells within the bone marrow, remains a formidable challenge in oncology. However, the treatment landscape is evolving, with CD38-directed therapies e

read more